Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (111-120 of 409) with videos related to

Pageof 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancerPhillip G Febbo, Aaron Thorner, Mark A Rubin, et al.
The American Journal of Surgical Pathology|August 26, 2006
Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinomaShuji Ogino, Robert D Odze, Takako Kawasaki, et al.
Gut|October 4, 2008
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerShuji Ogino, Katsuhiko Nosho, Gregory J Kirkner, et al.
British Journal of Cancer|March 18, 2016
Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expressionRebecca E Graff, Allison Meisner, Thomas U Ahearn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2018
Specific <sup>18</sup>F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding GlobulinBenjamin M Larimer, Frank Dubois, Emily Bloch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2005
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous componentShuji Ogino, Mohan Brahmandam, Mami Cantor, et al.
Cancer Research|June 3, 2006
Androgen-dependent regulation of Her-2/neu in prostate cancer cellsRaanan Berger, Douglas I Lin, Maria Nieto, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in miceSang Hyun Lee, George Poulogiannis, Saumyadipta Pyne, et al.
Gene|March 29, 2026
Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)Filippo Pederzoli, Hubert Pakula, Silvia Rodrigues, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 12, 2011
Investigative pathology: leading the post-genomic revolutionDavid M Berman, Marcus W Bosenberg, Robin L Orwant, et al.
Pageof 41

Showing results (111-120 of 409) with videos related to

Sort By:
Pageof 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancerPhillip G Febbo, Aaron Thorner, Mark A Rubin, et al.
The American Journal of Surgical Pathology|August 26, 2006
Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinomaShuji Ogino, Robert D Odze, Takako Kawasaki, et al.
Gut|October 4, 2008
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerShuji Ogino, Katsuhiko Nosho, Gregory J Kirkner, et al.
British Journal of Cancer|March 18, 2016
Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expressionRebecca E Graff, Allison Meisner, Thomas U Ahearn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2018
Specific <sup>18</sup>F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding GlobulinBenjamin M Larimer, Frank Dubois, Emily Bloch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2005
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous componentShuji Ogino, Mohan Brahmandam, Mami Cantor, et al.
Cancer Research|June 3, 2006
Androgen-dependent regulation of Her-2/neu in prostate cancer cellsRaanan Berger, Douglas I Lin, Maria Nieto, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in miceSang Hyun Lee, George Poulogiannis, Saumyadipta Pyne, et al.
Gene|March 29, 2026
Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)Filippo Pederzoli, Hubert Pakula, Silvia Rodrigues, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 12, 2011
Investigative pathology: leading the post-genomic revolutionDavid M Berman, Marcus W Bosenberg, Robin L Orwant, et al.
Pageof 41